RELMADA THERAPEUTICS INCRLMD
ASignal's systematic analysis rates RLMD as Bearish.
Reflects the latest available analysis · analyzed Oct 2, 2026
The case on RLMD
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health with debt-free balance sheet
- High cash reserves ($217.73M) relative to market cap
- Current ratio of 29.52x indicates exceptional liquidity
- RSI at 17.07 suggests deep oversold condition
- Negative operating cash flow ($-45.99M)
- Negative free cash flow ($-23.65M)
- Negative return on equity (-55.66%) and return on assets (-32.39%)
- Extremely low news coverage (only 1 source: Benzinga)
- No Reddit mentions indicating lack of retail interest
- Forward P/E of -8.85x indicates unprofitable earnings trajectory
See the full verdict on RLMD
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes RLMD
Most investors never get a second opinion, let alone several. ASignal runs RLMD past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.